GANX
Price
$1.85
Change
-$0.03 (-1.60%)
Updated
Jun 22 closing price
Capitalization
79.12M
44 days until earnings call
Intraday BUY SELL Signals
HOWL
Price
$0.37
Change
+$0.02 (+5.71%)
Updated
Jun 22 closing price
Capitalization
17.99M
44 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GANX vs HOWL

GANX vs HOWL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GANX vs. HOWL commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GANX is a StrongBuy and HOWL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (GANX: $1.86 vs. HOWL: $0.37)
Brand notoriety: GANX and HOWL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GANX: 131% vs. HOWL: 106%
Market capitalization -- GANX: $79.12M vs. HOWL: $17.99M
GANX [@Biotechnology] is valued at $79.12M. HOWL’s [@Biotechnology] market capitalization is $17.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GANX’s FA Score shows that 0 FA rating(s) are green whileHOWL’s FA Score has 1 green FA rating(s).

  • GANX’s FA Score: 0 green, 5 red.
  • HOWL’s FA Score: 1 green, 4 red.
According to our system of comparison, HOWL is a better buy in the long-term than GANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GANX’s TA Score shows that 5 TA indicator(s) are bullish while HOWL’s TA Score has 5 bullish TA indicator(s).

  • GANX’s TA Score: 5 bullish, 4 bearish.
  • HOWL’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, HOWL is a better buy in the short-term than GANX.

Price Growth

GANX (@Biotechnology) experienced а +6.00% price change this week, while HOWL (@Biotechnology) price change was -4.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.46%. For the same industry, the average monthly price growth was +1.63%, and the average quarterly price growth was +2204.18%.

Reported Earning Dates

GANX is expected to report earnings on Aug 06, 2026.

HOWL is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+4.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GANX($79.1M) has a higher market cap than HOWL($18M). HOWL (-41.579) and GANX (-42.391) have similar YTD gains . GANX has higher annual earnings (EBITDA): -19.6M vs. HOWL (-49.28M). HOWL has more cash in the bank: 46.4M vs. GANX (16.5M). GANX has less debt than HOWL: GANX (672K) vs HOWL (37.7M). GANX (0) and HOWL (0) have equivalent revenues.
GANXHOWLGANX / HOWL
Capitalization79.1M18M439%
EBITDA-19.6M-49.28M40%
Gain YTD-42.391-41.579102%
P/E RatioN/AN/A-
Revenue00-
Total Cash16.5M46.4M36%
Total Debt672K37.7M2%
TECHNICAL ANALYSIS
Technical Analysis
GANXHOWL
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GANX
Daily Signal:
Gain/Loss:
HOWL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UNCY7.861.01
+14.67%
Unicycive Therapeutics Inc
NU12.790.08
+0.63%
Nu Holdings Ltd
BKSY28.54-0.45
-1.55%
BlackSky Technology Inc
CENX49.52-2.19
-4.24%
Century Aluminum Company
GTBP0.48-0.03
-5.65%
GT Biopharma

GANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GANX has been loosely correlated with HOWL. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GANX jumps, then HOWL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GANX
1D Price
Change %
GANX100%
-1.33%
HOWL - GANX
42%
Loosely correlated
+5.35%
COYA - GANX
41%
Loosely correlated
+7.72%
AXON - GANX
36%
Loosely correlated
-3.16%
VIR - GANX
36%
Loosely correlated
+4.48%
VERA - GANX
35%
Loosely correlated
+9.52%
More

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been loosely correlated with GANX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if HOWL jumps, then GANX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
+5.35%
GANX - HOWL
42%
Loosely correlated
-1.33%
EDIT - HOWL
40%
Loosely correlated
+3.53%
SLDB - HOWL
39%
Loosely correlated
-0.36%
CRBU - HOWL
39%
Loosely correlated
+0.18%
BCRX - HOWL
38%
Loosely correlated
+1.67%
More